Two Sides of the Same Ecosystem.

One Partner for Both.


Whether you're building a company or backing one, the science and the regulation behind it have to hold up under scrutiny.

Too much of that risk surfaces late, after a term sheet is signed, or after a regulatory submission stalls.

PLG brings the same expertise that supports the world's largest pharmaceutical companies to the moments that matter most for startups and investors alike.



For Startups

Early-stage Biotech, MedTech, and digital health companies face outsized regulatory and scientific hurdles with limited internal resources.

As a Privileged Partner of EIT Health's Venture Centre of Excellence, PLG helps startups build a credible, de-risked pathway to market — turning regulatory readiness into a competitive advantage when raising capital.

Learn more about our Startup support

 

For Investors

Venture capital and private equity firms evaluating life sciences targets need more than financial due diligence. PLG supports investors with commercial, regulatory, and manufacturing due diligence, from target screening through post-merger integration.

Learn more about our Investor services

For Startups. For Investors.

 

Whether you're building a company or evaluating one, the path forward depends on getting the regulatory and commercial fundamentals right from the start.

Explore how PLG supports each side, from early-stage development to investment-grade due diligence.

1_Specialized-consultants-or-scientists-in-regulatory-activities-1920x900-1
Startup Regulatory & Innovation Support

A de-risked, credible regulatory pathway to market for early-stage Biotech, MedTech, and digital health companies preparing to raise their next round.

next-arrow
1_Investment Due Diligence Services
Investment Due Diligence Services

Independent commercial, regulatory, and manufacturing due diligence for life sciences deals, from target screening through post-merger integration.

arrow